 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lisanti Capital Growth LLC purchased a new position in PROCEPT BioRobotics Co. (NASDAQ:PRCT  Free Report) in the second quarter, according to its most recent Form 13F filing with the...

Lisanti Capital Growth LLC Takes Position in PROCEPT BioRobotics Co. (NASDAQ:PRCT)

PROCEPT BioRobotics Co. (NASDAQ:PRCT  Get Free Report) Director Morgan Colby Wood sold 25,000 shares of PROCEPT BioRobotics stock in a transaction that occurred on Monday, November 13th. The...

Morgan Colby Wood Sells 25,000 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) Stock

SAN JOSE, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the Company ), a surgical robotics company focused on advancing patient care by developing transformative...

PROCEPT BioRobotics to Present at the 35  Annual Piper Sandler Healthcare Conference in New York City

Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT  Get Free Report) have earned an average recommendation of Buy from the six research firms that are currently covering the firm...

PROCEPT BioRobotics Co. (NASDAQ:PRCT) Given Average Recommendation of "Buy" by Analysts

PROCEPT BioRobotics Co. (NASDAQ:PRCT  Get Free Report) has been assigned a consensus recommendation of Buy from the six research firms that are covering the stock, MarketBeat...

PROCEPT BioRobotics Co. (NASDAQ:PRCT) Receives $43.00 Average Target Price from Brokerages

In trading on Friday, shares of PROCEPT BioRobotics Corp (PRCT) crossed above their 200 day moving average of 33.33, changing hands as high as 34.99 per share. PROCEPT BioRobotics Corp...

PROCEPT BioRobotics (PRCT) Shares Cross Above 200 DMA

PROCEPT BioRobotics Corporation 2023 Q3 - Results - Earnings Call Presentation...

PROCEPT BioRobotics Corporation 2023 Q3 - Results - Earnings Call Presentation

SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the Company ), a surgical robotics company focused on advancing patient care by developing...

PROCEPT BioRobotics  Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in PROCEPT BioRobotics Corp (PRCT), where a total of 5,646 contracts have traded so far...

Notable Wednesday Option Activity: PRCT, IGT, CYTK

SVB Leerink assumed coverage on shares of PROCEPT BioRobotics (NASDAQ:PRCT  Free Report) in a research report sent to investors on Monday morning, Benzinga reports. The firm issued an...

PROCEPT BioRobotics (NASDAQ:PRCT) Now Covered by SVB Leerink

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in Redwood City, CA.

Watchers	292
52-Wk Low	$24.83
52-Wk High	$45.07

Market Cap	$2.02B
Volume (M)	707,534.00
52-Wk High	$45.07
52-Wk Low	$24.83

PRCT Procept BioRobotics Corp

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community